en · de · es · fr · pt
tb-500-notes.peptides8425.com › Guide › Research Framing And Evidence Base — Research Overview

Research Framing And Evidence Base — Research Overview

By Editorial Desk · published 2026-05-12 · last reviewed 2026-07-03 · Guide

This is a working overview of heptapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2026-07-03 and is reviewed periodically as new material appears.

Research Framing and Evidence Base

Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.

Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.

Identity and Reported Background

TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.

Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.

Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.

Tb-500 at a glance

PropertyValueNotes
Common synonymsThymosin beta-4 fragment; TB4 fragmentNaming is inconsistent across suppliers and publications
Reported sequenceAc-LKKTETQCorresponds to residues 17-23 of the parent protein
Frequently cited registry number77591-33-4Associated with full-length thymosin beta-4 rather than the fragment
Common supplied formFreeze-dried solidOften presented as an acetate or trifluoroacetate salt
Regulatory treatmentVaries by countryFrequently handled as a research chemical; not broadly approved as a therapeutic

Identity and Research Background

Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.

Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.

TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.

Related pages on this site

Handling, Storage and Analytical Checks

Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.

Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.

Storage, Handling, and Analytical Checks

Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.

The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.

Notes from published material

It also raised concerns among those who had bought the ATI Radeon HD 2900 XT graphics card, which came with a voucher for The Black Box, but Valve clarified that only the retail version of The Black Box had been cancelled. While Valve never expressed its reasons for this decision, industry writers speculated that it might have been to increase profits on retail copies or to avoid customer confusion between similar game packages and their availability across the platforms.

The earliest study of endocrinology began in China. The Chinese were isolating sex and pituitary hormones from human urine and using them for medicinal purposes by 200 BC. They used many complex methods, such as sublimation of steroid hormones. Another method specified by Chinese texts—the earliest dating to 1110—specified the use of saponin (from the beans of Gleditsia sinensis) to extract hormones, but gypsum (containing calcium sulfate) was also known to have been used. Although most of the relevant tissues and endocrine glands had been identified by early anatomists, a more humoral approach to understanding biological function and disease was favoured by the ancient Greek and Roman thinkers such as Aristotle, Hippocrates, Lucretius, Celsus, and Galen, according to Freeman et al., and these theories held sway until the advent of germ theory, physiology, and organ basis of pathology in the 19th century. In 1849, Arnold Berthold noted that castrated cockerels did not develop combs and wattles or exhibit overtly male behaviour. He found that replacement of testes back into the abdominal cavity of the same bird or another castrated bird resulted in normal behavioural and morphological development, and he concluded (erroneously) that the testes secreted a substance that "conditioned" the blood that, in turn, acted on the body of the cockerel. In fact, one of two other things could have been true: that the testes modified or activated a constituent of the blood or that the testes removed an inhibitory factor from the blood.

Haber's new unit was called Pioneer Regiment 35. After brief training in Berlin, Hahn, together with physicists James Franck and Gustav Hertz, was sent to Flanders again to scout for a site for a first gas attack. He did not witness the attack because he and Franck were off selecting a position for the next attack. Transferred to Poland, at the Battle of Bolimów on 12 June 1915, they released a mixture of chlorine and phosgene gas. Some German troops were reluctant to advance when the gas started to blow back, so Hahn led them across No Man's land. He witnessed the death agonies of Russians they had poisoned, and unsuccessfully attempted to revive some with gas masks. On their next attempt on 7 July, the gas again blew back on German lines, and Hertz was poisoned. This assignment was interrupted by a mission at the front in Flanders and again in 1916 by a mission to Verdun to introduce shells filled with phosgene to the Western Front. Then once again he was hunting along both fronts for sites for gas attacks. In December 1916 he joined the new gas command unit at Imperial Headquarters. Between operations, Hahn returned to Berlin, where he was able to slip back to his old laboratory and work with Meitner, continuing with their research. In September 1917 he was one of three officers, disguised in Austrian uniforms, sent to the Isonzo front in Italy to find a suitable location for an attack, using newly developed rifled minenwerfers that simultaneously hurled hundreds of containers of poison gas onto enemy targets.

A maltoside is a glycoside with maltose as the glycone (sugar) functional group. Among the most common are alkyl maltosides, which contain hydrophobic alkyl chains as the aglycone. Given their amphiphilic properties, these comprise a class of detergents, where variation in the alkyl chain confers a range of detergent properties including CMC and solubility. Maltosides are most often used for the solubilization and purification of membrane proteins.

== Philanthropy == In 2017, Springer founded the 501(c)(3) organization Institute for Protein Innovation, which advances open antibody and protein tools for the scientific community, and funded it with a $10 million foundational grant. He also serves on the Board of Trustees of the Marine Biological Laboratory (MBL). Springer has endowed professorships at Harvard Medical School, Boston Children's Hospital, and Berkeley.

Sources: en.wikipedia.org

Further detail

In 2009, IGN named Newell one of the top 100 game creators, writing that it was "almost impossible to gauge" Valve's influence on game design, technology and the video games industry. In December 2010, Forbes listed Newell as "A Name You Need to Know", primarily for his work on Steam and partnerships with multiple major developers. In 2013, Newell was added to the Academy of Interactive Arts & Sciences Hall of Fame and received the BAFTA Fellowship for his contributions to the video game industry. According to Josh Weier, the project lead for Portal 2 (2011), Newell became less involved in game development after Portal 2 as many developers would blindly agree with his ideas due to his position. As of 2024, Newell had become less involved in Valve and was spending more time on personal projects.

=== Other transplants and induced regeneration === There is ongoing research and development into synthetic biology based methods for inducing regeneration in humans as well the creation of transplantable artificial organs.

Recently, sequence context-specific amino acid similarities have been derived that do not need substitution matrices but that rely on a library of sequence contexts instead. Using this idea, a context-specific extension of the popular BLAST program has been demonstrated to achieve a twofold sensitivity improvement for remotely related sequences over BLAST at similar speeds (CS-BLAST).

=== Caloric value and labeling === Nutritional labeling of erythritol in food products varies from country to country. Some places, such as Japan and the European Union (EU), label it as zero-calorie. Under Food and Drug Administration (FDA) labeling requirements in the United States, erythritol has a caloric value of zero.

Sources: en.wikipedia.org

Background from the literature

=== Urinary glucose testing === Women with GDM may have high glucose levels in their urine (glucosuria). Although dipstick testing is widely practiced, it performs poorly, and discontinuing routine dipstick testing has not been shown to cause underdiagnosis where universal screening is performed. Increased glomerular filtration rates during pregnancy contribute to some 50% of women having glucose in their urine on dipstick tests at some point during their pregnancy. Glomerular filtration rates increase during pregnancy due to an increase in blood volume to support the fetus. The sensitivity of glucosuria for GDM in the first two trimesters is only around 10%, and the positive predictive value is around 20%.

== External links == Actin Staining Techniques (Live and Fixed Cell Staining) Eukaryotic Linear Motif resource motif class LIG_Actin_RPEL_3 Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_1 Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_2 3D macromolecular structures of actin filaments from the EM Data Bank(EMDB)

=== Dosage forms === Lidocaine, usually in the form of its hydrochloride salt, is available in various forms including many topical formulations and solutions for injection or infusion. It is also available as a transdermal patch, which is applied directly to the skin.

=== 1964 === January 12: the Arab-dominated government of the Zanzibar Sultanate is overthrown by John Okello, establishing the new people's republic. The new regime orders a massacre against minorities, resulting in the deaths of hundred to thousand Arabs and South Asians in Zanzibar. January 27: France recognizes the People's Republic of China. The Republic of China severs diplomatic relations with France on February 10. March 31–April 1: A military-led coup d'état overthrows president João Goulart in Brazil. Goulart's proposals, such as land reform and bigger control of the state in the economy, were seen as communist. April 20: U.S. President Lyndon Johnson in New York, and Soviet First Secretary Nikita Khrushchev in Moscow, announce simultaneously plans to cut back production of materials for making nuclear weapons. May 27: Jawaharlal Nehru dies. The Colombian conflict begins. July 4: The Rhodesian Bush War begins when African nationalist / Marxist insurgents rebel against colonial rule in Rhodesia (modern-day Zimbabwe). Nyasaland (renamed Malawi upon independence) becomes independent from the UK. August 4: U.S. President Lyndon B. Johnson claims that North Vietnamese naval vessels had fired on two American destroyers in the Gulf of Tonkin. Although there was a first attack, it was later shown that American vessels had entered North Vietnamese territory first, and that the claim of second attack had been unfounded. The Gulf of Tonkin incident leads to the open involvement of the United States in the Vietnam War, after the Gulf of Tonkin Resolution.

He believed that some of the effects of increased CO2 levels are favourable and not taken into account by climate scientists, such as increased agricultural yield, and further that the positive benefits of CO2 likely outweigh the negative effects. He was skeptical about the simulation models used to predict climate change, arguing that political efforts to reduce causes of climate change distract from other global problems that should take priority. He was awarded the 1996 Lewis Thomas Prize and the 2000 Templeton Prize. He said that "As we look out into the Universe and identify the many accidents of physics and astronomy that have worked together to our benefit, it almost seems as if the Universe must in some sense have known that we were coming."

Sources: en.wikipedia.org

Frequently asked questions

What mechanism is most often proposed?

The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.

Do human trials of the short fragment exist?

Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.

How is the material usually detected in a sample?

Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.

What is TB-500 made of?

Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.

Network